JP7405511B2 - How to improve skin brightness - Google Patents
How to improve skin brightness Download PDFInfo
- Publication number
- JP7405511B2 JP7405511B2 JP2019044752A JP2019044752A JP7405511B2 JP 7405511 B2 JP7405511 B2 JP 7405511B2 JP 2019044752 A JP2019044752 A JP 2019044752A JP 2019044752 A JP2019044752 A JP 2019044752A JP 7405511 B2 JP7405511 B2 JP 7405511B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- skin
- external composition
- salts
- wiping
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 claims description 72
- 239000007788 liquid Substances 0.000 claims description 62
- -1 ascorbic acid glucoside Chemical class 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 51
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 47
- 235000010323 ascorbic acid Nutrition 0.000 claims description 29
- 229960005070 ascorbic acid Drugs 0.000 claims description 29
- 239000011668 ascorbic acid Substances 0.000 claims description 29
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 20
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 19
- 229920000742 Cotton Polymers 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 229930182478 glucoside Natural products 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims 1
- 235000002020 sage Nutrition 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 68
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 41
- 230000000694 effects Effects 0.000 description 29
- 230000002087 whitening effect Effects 0.000 description 29
- 235000002639 sodium chloride Nutrition 0.000 description 28
- 235000011187 glycerol Nutrition 0.000 description 23
- 239000004615 ingredient Substances 0.000 description 19
- 150000003839 salts Chemical class 0.000 description 17
- 239000000835 fiber Substances 0.000 description 14
- 210000000434 stratum corneum Anatomy 0.000 description 12
- 229910001413 alkali metal ion Inorganic materials 0.000 description 11
- 239000006210 lotion Substances 0.000 description 10
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 9
- 229960004705 kojic acid Drugs 0.000 description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 229910052783 alkali metal Inorganic materials 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 235000015165 citric acid Nutrition 0.000 description 8
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 7
- 241000218378 Magnolia Species 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 5
- 229960000401 tranexamic acid Drugs 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 159000000003 magnesium salts Chemical class 0.000 description 4
- 229910001414 potassium ion Inorganic materials 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical class C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 229910001415 sodium ion Inorganic materials 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 3
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 3
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 3
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 3
- 229920002079 Ellagic acid Polymers 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 241000218377 Magnoliaceae Species 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241001290151 Prunus avium subsp. avium Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 150000001860 citric acid derivatives Chemical class 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 229960002852 ellagic acid Drugs 0.000 description 3
- 235000004132 ellagic acid Nutrition 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 2
- DMPZOHHHRRENRS-UHFFFAOYSA-N 2,3-Di-O-methylellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(OC)C(OC)=C4OC(=O)C3=C1 DMPZOHHHRRENRS-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- 235000006463 Brassica alba Nutrition 0.000 description 2
- 235000011371 Brassica hirta Nutrition 0.000 description 2
- 244000178993 Brassica juncea Species 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 244000077995 Coix lacryma jobi Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 150000005332 diethylamines Chemical class 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002169 ethanolamines Chemical class 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 150000003956 methylamines Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 229940116257 pepper extract Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960004492 suprofen Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- SWGARUWMPUMTGP-SHRWCKKSSA-N (2R)-2-[(1S)-1,2-dihydroxy-3-oxobutyl]-3,4-dihydroxy-2H-furan-5-one Chemical compound C(C)(=O)C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O SWGARUWMPUMTGP-SHRWCKKSSA-N 0.000 description 1
- LFJFTHGNGAQWQQ-XVBAXELQSA-N (2R)-2-[(Z,1S)-1,2-dihydroxy-3-oxoicos-11-enyl]-3,4-dihydroxy-2H-furan-5-one Chemical compound C(CCCCCCC\C=C/CCCCCCCC)(=O)C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O LFJFTHGNGAQWQQ-XVBAXELQSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CAKDFKUXFMLCAR-UIOGXPPZSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-methoxycarbonyl-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@]1(C)CC[C@](C[C@H]14)(C)C(=O)OC)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O CAKDFKUXFMLCAR-UIOGXPPZSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- REHQLKUNRPCYEW-UHFFFAOYSA-N 1-methylcyclohexane-1-carboxylic acid Chemical compound OC(=O)C1(C)CCCCC1 REHQLKUNRPCYEW-UHFFFAOYSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- LVOGXJMCDAOKSQ-UHFFFAOYSA-N 10-oxo-10-propan-2-yloxydecanoic acid Chemical compound CC(C)OC(=O)CCCCCCCCC(O)=O LVOGXJMCDAOKSQ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- IKVCSHRLYCDSFD-UHFFFAOYSA-N 2-hexadecanoyloxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCC IKVCSHRLYCDSFD-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- BXCRLBBIZJSWNS-UHFFFAOYSA-N 2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCO BXCRLBBIZJSWNS-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- WLSLSHYMTUVYSP-ZANVPECISA-N 3,3'-di-O-methylellagic acid Natural products COC1=C(O)C=C2[C@@H]3[C@@H]1OC(=O)c4cc(O)c(OC)c(OC2=O)c34 WLSLSHYMTUVYSP-ZANVPECISA-N 0.000 description 1
- LXEQIOGTMDLLEC-UHFFFAOYSA-N 3,4,3'-Tri-O-methylellagic acid Chemical compound OC1=C(OC)C(OC2=O)=C3C4=C2C=C(OC)C(OC)=C4OC(=O)C3=C1 LXEQIOGTMDLLEC-UHFFFAOYSA-N 0.000 description 1
- KLAGYIBJNXLDTL-UHFFFAOYSA-N 3,8-di-o-methylellagic acid Chemical compound O1C(=O)C2=CC(O)=C(OC)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 KLAGYIBJNXLDTL-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- LHJCLTLPXXKFTJ-UHFFFAOYSA-N 3-[4-hydroxy-3-(4-hydroxy-3-prop-2-enylphenyl)phenyl]propane-1,2-diol Chemical compound OCC(O)CC1=CC=C(O)C(C=2C=C(CC=C)C(O)=CC=2)=C1 LHJCLTLPXXKFTJ-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- SFUCGABQOMYVJW-UHFFFAOYSA-N 4-(4-Hydroxyphenyl)-2-butanol Chemical compound CC(O)CCC1=CC=C(O)C=C1 SFUCGABQOMYVJW-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical compound NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- XHPXSMWMAJGYBS-UHFFFAOYSA-N 4-[[(4-carboxycyclohexyl)methylamino]methyl]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1CNCC1CCC(C(O)=O)CC1 XHPXSMWMAJGYBS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241001481760 Erethizon dorsatum Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 241000735598 Galbulimima belgraveana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- ACEWLPOYLGNNHV-UHFFFAOYSA-N Ibuprofen piconol Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(=O)OCC1=CC=CC=N1 ACEWLPOYLGNNHV-UHFFFAOYSA-N 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 235000014196 Magnolia kobus Nutrition 0.000 description 1
- 240000005378 Magnolia kobus Species 0.000 description 1
- 241000218397 Magnolia x soulangeana Species 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- WGHKJYWENWLOMY-XVNBXDOJSA-N N-feruloylserotonin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)NCCC=2C3=CC(O)=CC=C3NC=2)=C1 WGHKJYWENWLOMY-XVNBXDOJSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 241001233474 Prunus apetala Species 0.000 description 1
- 235000003838 Prunus apetala Nutrition 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241000814102 Prunus conradinae Species 0.000 description 1
- 235000004411 Prunus conradinae Nutrition 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 235000004102 Prunus grayana Nutrition 0.000 description 1
- 240000005874 Prunus grayana Species 0.000 description 1
- 235000013946 Prunus jamasakura Nutrition 0.000 description 1
- 244000059026 Prunus jamasakura Species 0.000 description 1
- 235000015527 Prunus lannesiana Nutrition 0.000 description 1
- 244000141698 Prunus lannesiana Species 0.000 description 1
- 235000013993 Prunus maximowiczii Nutrition 0.000 description 1
- 240000001052 Prunus maximowiczii Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- NDXSDWFOYZXARW-UHFFFAOYSA-N Trimethylellagsaeure Natural products COC1=C(OC)C(OC2=O)=C3C4=C2C=C(OC)C(O)=C4OC(=O)C3=C1 NDXSDWFOYZXARW-UHFFFAOYSA-N 0.000 description 1
- JDLSRXWHEBFHNC-UHFFFAOYSA-N Ufenamate Chemical compound CCCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 JDLSRXWHEBFHNC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- WGHKJYWENWLOMY-CLTKARDFSA-N cis-Moschamine Natural products C1=C(O)C(OC)=CC(\C=C/C(=O)NCCC=2C3=CC(O)=CC=C3NC=2)=C1 WGHKJYWENWLOMY-CLTKARDFSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- SUSRLLXAXAIZPH-OBPIAQAESA-N hydroquinone beta-D-glucopyranoside Natural products OC[C@H]1O[C@@H](Cc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O SUSRLLXAXAIZPH-OBPIAQAESA-N 0.000 description 1
- 229950005954 ibuprofen piconol Drugs 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- JXNPEDYJTDQORS-UHFFFAOYSA-N linoleyl alcohol Natural products CCCCCC=CCC=CCCCCCCCCO JXNPEDYJTDQORS-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- WORCCYVLMMTGFR-UHFFFAOYSA-M loxoprofen sodium Chemical compound [Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 WORCCYVLMMTGFR-UHFFFAOYSA-M 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- BBEJNBLSSWFDSN-UHFFFAOYSA-N methylamino benzoate Chemical compound CNOC(=O)C1=CC=CC=C1 BBEJNBLSSWFDSN-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- CTIQLGJVGNGFEW-UHFFFAOYSA-L naphthol yellow S Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C([O-])=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 CTIQLGJVGNGFEW-UHFFFAOYSA-L 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229950006098 orthocaine Drugs 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960003981 proparacaine Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 229940044609 sulfur dioxide Drugs 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- HVUCRESARJLKJG-UHFFFAOYSA-K trisodium 1-hexadecoxyhexadecane phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC HVUCRESARJLKJG-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229950010121 ufenamate Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
特許法第30条第2項適用 ▲1▼ウェブサイトのアドレス:https://www.amazon.co.jp/%E3%82%B1%E3%82%B7%E3%83%9F%E3%83%B3-%E5%B0%8F%E6%9E%97%E8%A3%BD%E8%96%AC-%E3%82%B1%E3%82%B7%E3%83%9F%E3%83%B3%E3%81%B5%E3%81%8D%E3%81%A8%E3%82%8A%E3%82%B7%E3%83%9F%E5%AF%BE%E7%AD%96%E6%B6%B2-160ml/dp/B07KZFYT9C ウェブサイトの掲載日: 平成30年11月30日Article 30, Paragraph 2 of the Patent Act applies ▲1▼Website address: https://www. amazon. co. jp/%E3%82%B1%E3%82%B7%E3%83%9F%E3%83%B3-%E5%B0%8F%E6%9E%97%E8%A3%BD%E8%96% AC-%E3%82%B1%E3%82%B7%E3%83%9F%E3%83%B3%E3%81%B5%E3%81%8D%E3%81%A8%E3%82%8A %E3%82%B7%E3%83%9F%E5%AF%BE%E7%AD%96%E6%B6%B2-160ml/dp/B07KZFYT9C Website publication date: November 30, 2018
本発明は、肌の明度を向上させる技術に関する。 The present invention relates to technology for improving skin brightness.
皮膚のシミ、そばかす、くすみ、黒ずみ、肝斑、老人性色素斑等の色素沈着は、紫外線曝露、ホルモンの異常や物理的な刺激等が原因となってメラニンが過剰に形成され、これが皮膚内に沈着することによって生じることが分かっている。このような皮膚の色素沈着は、肌の明度を下げ、特に女性にとって美容上の大きな悩みとなっている。 Pigmentation such as spots, freckles, dullness, dark spots, melasma, and senile pigmentation on the skin is caused by excessive melanin formation in the skin due to UV exposure, hormonal abnormalities, physical stimulation, etc. It is known that this is caused by the deposition of Such skin pigmentation lowers the brightness of the skin and is a major cosmetic problem, especially for women.
従来、アスコルビン酸及びその誘導体等の、メラニン生成を抑制及び/又は生成メラニンを希釈化する成分は、いわゆる美白成分として知られており、皮膚の色素沈着抑制効果を得ることを目的として美白用の外用組成物に広く使用されている。しかしながら、皮膚の色素沈着抑制効果を美白成分の作用に依存するだけでは、消費者ニーズを十分に満足できているとは言えないのが現状である。 Conventionally, ingredients that suppress melanin production and/or dilute melanin production, such as ascorbic acid and its derivatives, have been known as so-called skin-whitening ingredients, and have been used as whitening ingredients for the purpose of suppressing skin pigmentation. Widely used in external compositions. However, the current situation is that relying solely on the effect of whitening ingredients to suppress skin pigmentation does not fully satisfy consumer needs.
そこで、美白成分による皮膚の色素沈着抑制効果を向上させる処方が検討されている。例えば特許文献1では、外用組成物において、アスコルビン酸及びその誘導体に、モクレン科モクレン属植物の抽出物を併用することによって、メラニンの生成抑制作用が高まることが記載されている。 Therefore, formulations that improve the effect of whitening ingredients on suppressing skin pigmentation are being considered. For example, Patent Document 1 describes that in a composition for external use, the effect of suppressing melanin production is enhanced by using ascorbic acid and its derivatives together with an extract of a plant of the genus Magnolia of the family Magnoliaceae.
一方、皮膚の正常な新陳代謝において垢となって落屑されるはずの角質層(老化角質)が角質層の表面にとどまることにより、肌を、透明感が低下したくすみのある外観へと変化させると考えられている。そこで、角質層表面の老化角質を除去することでくすみを改善することを目的として、拭き取り用化粧水が提案されている。 On the other hand, the stratum corneum (aged stratum corneum), which should be desquamated as plaque during normal skin metabolism, remains on the surface of the stratum corneum, causing the skin to become less transparent and dull. It is considered. Therefore, a wiping lotion has been proposed for the purpose of improving dullness by removing aged keratin on the surface of the stratum corneum.
拭き取り用化粧水においても、角質除去効果を向上させる処方が検討されており、例えば特許文献2では、拭き取り用化粧水において、塩類泉に分類される温泉水を配合することによって、角質除去効果が高まることが記載されている。 Formulas that improve the exfoliating effect of wiping lotions are also being considered; for example, in Patent Document 2, in wiping lotions, the exfoliating effect is enhanced by blending hot spring water classified as salt springs. It is stated that.
拭き取り用化粧水によって角質層表面の老化角質が除去されることで、老化角質に含まれていた排出されるべきメラニンも一緒に除去されることとなる。このため、ふき取り操作によって、透明感が向上してくすみが改善されたような外観が得られると考えられる。一方で、メラニンは基底層で産生され、タ-ンオ-バ-によって肌表面まで押し出されることから、明度の低下した肌において、メラニンは基底層から角質層表面の細胞まで連続的に存在しうる。このため、角質層の表面の角質を除去しただけで得られる肌外観の変化は、明度の低下した肌を効果的に明度向上させるまでには到底至らない。 When the wiping lotion removes aged keratin on the surface of the stratum corneum, melanin that was contained in the aged keratin and should be excreted is also removed. Therefore, it is thought that the wiping operation provides an appearance with improved transparency and reduced dullness. On the other hand, melanin is produced in the basal layer and is pushed out to the skin surface through turnover, so in skin with decreased brightness, melanin can exist continuously from the basal layer to the cells on the surface of the stratum corneum. . For this reason, the change in skin appearance obtained simply by removing the surface of the stratum corneum cannot effectively improve the brightness of skin with decreased brightness.
このため、肌明度を効果的に向上させるには、ふき取りでは除去されない皮膚細胞において積極的にメラニン生成を抑制及び/又は生成メラニンを希釈化する美白成分が有効と考えられる。しかしながら、美白に対する消費者の要望は年々高まっており、製剤処方のみで得られる美白効果では、消費者の要望を満足できなくなっている。そこで、今後、益々高まる消費者の要望に追従するためにも、肌明度を効果的に向上させるより優れた技術の開発が望まれている。 Therefore, in order to effectively improve skin brightness, it is considered effective to use a whitening ingredient that actively suppresses melanin production and/or dilutes the melanin produced in skin cells that cannot be removed by wiping. However, consumer demand for skin whitening is increasing year by year, and it is no longer possible to satisfy consumer demand with the whitening effect obtained only through pharmaceutical formulations. Therefore, in order to keep up with the ever-increasing demands of consumers, there is a desire to develop better technology that can effectively improve skin brightness.
そこで、本発明の目的は、肌明度を向上させることにより、優れた美白効果を奏する技術を提供することである。 Therefore, an object of the present invention is to provide a technique that achieves an excellent whitening effect by improving skin brightness.
本発明者は鋭意検討を行ったところ、美白成分を含む液状外用組成物を含浸させた清拭具を用いて肌表面を拭き取ることで、肌の明度が各段向上することを見出した。本発明は、この知見に基づいて、更に検討を重ねることにより完成したものである。即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. 美白成分を含む液状外用組成物を含浸させた清拭具を用いて肌表面を拭き取ることを含む、肌の明度向上方法。
項2. 前記肌が、メラニンが沈着している肌の部分を含む、項1に記載の方法。
項3. 前記液状外用組成物が、一価低級アルコール及び/又はグリセリンを含む、項1又は2に記載の方法。
項4. 前記液状外用組成物がクエン酸イオンを含む、項1~3のいずれかに記載の方法。
項5. 前記液状外用組成物がアルカリ金属イオンを含む、項1~4のいずれかに記載の方法。
項6. 前記美白成分が、アスコルビン酸グルコシドである、項1~5のいずれかに記載の方法。
項7. 前記清拭具が綿繊維のみから構成される、項1~6のいずれかに記載の方法。
項8. 清拭具に含浸させて肌表面を拭き取るために用いられる、美白成分を含む液状外用組成物。
The inventors of the present invention have conducted extensive research and found that the brightness of the skin can be improved to various degrees by wiping the skin surface using a wiping tool impregnated with a liquid external composition containing a whitening ingredient. The present invention was completed through further studies based on this knowledge. That is, the present invention provides the inventions of the following aspects.
Item 1. A method for improving skin brightness, comprising wiping the skin surface using a wiping tool impregnated with a liquid external composition containing a whitening ingredient.
Item 2. Item 2. The method according to Item 1, wherein the skin includes a skin area where melanin is deposited.
Item 3. Item 3. The method according to item 1 or 2, wherein the liquid external composition contains a monohydric lower alcohol and/or glycerin.
Item 4. Item 4. The method according to any one of Items 1 to 3, wherein the liquid external composition contains citrate ions.
Item 5. Item 5. The method according to any one of Items 1 to 4, wherein the liquid external composition contains an alkali metal ion.
Item 6. Item 6. The method according to any one of Items 1 to 5, wherein the whitening ingredient is ascorbic acid glucoside.
Section 7. 7. The method according to any one of items 1 to 6, wherein the wiping tool is composed only of cotton fibers.
Section 8. A liquid external composition containing a whitening ingredient that is used to impregnate a cleaning tool and wipe the skin surface.
本発明の方法によると、優れた肌明度向上効果が得られる。特に、シミなどのメラニンが沈着している肌の部分を拭き取ることで、より一層優れた肌明度向上効果が得られる。 According to the method of the present invention, an excellent effect of improving skin brightness can be obtained. In particular, by wiping off areas of the skin where melanin is deposited, such as age spots, an even greater effect on skin brightness can be obtained.
1.肌の明度向上方法
本発明の肌の明度向上方法は、美白成分を含む液状外用組成物を含浸させた清拭具を用いて肌表面を拭き取ることを含む。以下、本発明の肌の明度向上方法について詳述する。
1. Method for Improving Skin Brightness The method for improving skin brightness of the present invention includes wiping the skin surface using a wiping tool impregnated with a liquid external composition containing a whitening ingredient. Hereinafter, the method for improving skin brightness of the present invention will be described in detail.
美白成分
本発明の方法に用いる液状外用組成物は、美白成分を含む。美白成分としては特に限定されず、メラニン生成を抑制及び/又は生成メラニンを希釈化する作用を有するものであればよい。具体的には、アスコルビン酸及びその誘導体、ハイドロキノン及びその誘導体、コウジ酸及びその誘導体、エラグ酸及びその誘導体、トラネキサム酸及びその誘導体、レゾルシン誘導体、ニコチン酸誘導体、セロトニン誘導体、サリチル酸誘導体、アルキルフェノール類、アスタキサンチン、α-リポ酸、パンテテインスルホン酸カルシウム等の化合物;胎盤抽出物、カミツレ抽出物、ソウハクヒ抽出物、ユキノシタ抽出物、カッコンエキス、オウゴンエキス、ブドウ種子エキス、ブドウ葉エキス、オタネニンジンエキス、コンフリー葉エキス、トウキエキス、エイジツエキス、ウメ果実エキス、イチョウ葉エキス、甘草エキス、ムラサキシキブ抽出物、米糠抽出物及びその加水分解物、白芥子抽出物及びその加水分解物、白芥子発酵物、シャクヤク抽出物又はその加水分解物、乳酸菌醗酵穀類(米、発芽米、麦、豆等)、ハス種子抽出物及びその加水分解物、ハス種子発酵物、ハトムギ加水分解物、ハトムギ種子発酵物、ローヤルゼリー発酵物、酒粕発酵物等の、植物及び動物抽出物並びにその加水分解物及び発酵物が挙げられる。
Whitening ingredient The liquid external composition used in the method of the present invention contains a whitening ingredient. There are no particular limitations on the whitening component, as long as it has the effect of suppressing melanin production and/or diluting the produced melanin. Specifically, ascorbic acid and its derivatives, hydroquinone and its derivatives, kojic acid and its derivatives, ellagic acid and its derivatives, tranexamic acid and its derivatives, resorcinol derivatives, nicotinic acid derivatives, serotonin derivatives, salicylic acid derivatives, alkylphenols, Compounds such as astaxanthin, α-lipoic acid, and calcium pantetheinsulfonate; placenta extract, chamomile extract, Japanese sardine extract, saxifrage extract, cuckoo extract, scutellariae extract, grape seed extract, grape leaf extract, Panax ginseng extract, and Free leaf extract, Angelica extract, Ajitsu extract, Plum fruit extract, Ginkgo biloba extract, Licorice extract, Purple pepper extract, Rice bran extract and its hydrolyzate, White mustard extract and its hydrolyzate, White mustard fermented product, Peony Extracts or hydrolysates thereof, lactic acid bacteria-fermented grains (rice, germinated rice, barley, beans, etc.), lotus seed extracts and hydrolysates thereof, fermented lotus seeds, hydrolyzed coix seeds, fermented coix seeds, fermented royal jelly Examples include plant and animal extracts, and hydrolysates and fermented products thereof, such as fermented products and fermented products of sake lees.
アスコルビン酸及びその誘導体としては、アスコルビン酸グルコシド(アスコルビン酸2-グルコシド);アスコルビン酸モノステアレート、アスコルビン酸モノパルミテート、アスコルビン酸モノオレート等のアスコルビン酸モノアルキルエステル類;アスコルビン酸モノリン酸エステル及びそのマグネシウム塩等のアスコルビン酸モノエステル類;アスコルビン酸ジステアレート、アスコルビン酸ジパルミテート、アスコルビン酸ジオレート等のアスコルビン酸ジアルキルエステル類;アスコルビン酸ジリン酸エステル及びその塩等のアスコルビン酸ジエステル類;アスコルビン酸トリステアレート、アスコルビン酸トリパルミテート、アスコルビン酸トリオレート等のトリアルキルエステル類;アスコルビン酸トリリン酸エステル等のアスコルビン酸トリエステル類;3-O-エチル,6-アセチル-アスコルビン酸、3-O-エチル,6-ブチルアスコルビン酸、3-O-エチル,6-ラウロイルアスコルビン酸、3-O-エチル,6-パルミトイルアスコルビン酸、3-O-エチル,6-オレオイルアスコルビン酸、3-O-エチル,6-ステアロイルアスコルビン酸、3-O-エチル,6-ベヘルミノイル-アスコルビン酸等が挙げられる。これらのアスコルビン酸及びその誘導体は、L体又はD体のいずれであってもよいが、好ましくはL体が挙げられる。 Ascorbic acid and its derivatives include ascorbic acid glucoside (ascorbic acid 2-glucoside); ascorbic acid monoalkyl esters such as ascorbic acid monostearate, ascorbic acid monopalmitate, and ascorbic acid monooleate; ascorbic acid monophosphate esters and their like; Ascorbic acid monoesters such as magnesium salts; ascorbic acid dialkyl esters such as ascorbic acid distearate, ascorbyl acid dipalmitate, and ascorbic acid dioleate; ascorbic acid diesters such as ascorbic acid diphosphate and its salts; ascorbic acid tristearate, Trialkyl esters such as ascorbic acid tripalmitate and ascorbic acid triolate; ascorbic acid triesters such as ascorbic acid triphosphate; 3-O-ethyl, 6-acetyl-ascorbic acid, 3-O-ethyl, 6 -Butyl ascorbic acid, 3-O-ethyl, 6-lauroyl ascorbic acid, 3-O-ethyl, 6-palmitoyl ascorbic acid, 3-O-ethyl, 6-oleoylascorbic acid, 3-O-ethyl, 6- Examples include stearoyl ascorbic acid, 3-O-ethyl, 6-behelminoyl-ascorbic acid, and the like. These ascorbic acids and their derivatives may be either L-form or D-form, but L-form is preferred.
ハイドロキノン及びその誘導体としては、ハイドロキノン、アルブチン(ハイドロキノン-β-D-グルコピラノシド)、α-アルブチン(ハイドロキノン-α-D-グルコピラノシド)、ハイドロキノン配糖体等が挙げられる。 Hydroquinone and its derivatives include hydroquinone, arbutin (hydroquinone-β-D-glucopyranoside), α-arbutin (hydroquinone-α-D-glucopyranoside), hydroquinone glycosides, and the like.
コウジ酸及びその誘導体としては、コウジ酸、コウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシド等が挙げられる。 Examples of kojic acid and derivatives thereof include kojic acid, kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, and kojic acid dibutyrate, kojic acid ethers, and kojic acid glucoside.
エラグ酸及びその誘導体としては、エラグ酸、3,4-ジ-o-メチルエラグ酸、3,3'-ジ-o-メチルエラグ酸、3,3',4-トリ-o-メチルエラグ酸、3,3',4,4'-テトラ-o-メチル-5-メトキシエラグ酸、3-o-エチル-4-o-メチル-5-ヒドロキシエラグ酸、及びこれらの塩が挙げられる。 Examples of ellagic acid and its derivatives include ellagic acid, 3,4-di-o-methylellagic acid, 3,3'-di-o-methylellagic acid, 3,3',4-tri-o-methylellagic acid, 3, Examples include 3',4,4'-tetra-o-methyl-5-methoxyellagic acid, 3-o-ethyl-4-o-methyl-5-hydroxyellagic acid, and salts thereof.
トラネキサム酸及びその誘導体としては、トラネキサム酸(トランス-4-アミノメチルシクロヘキサンカルボン酸(t-AMCHA))、トラネキサム酸の二量体(例えば、塩酸トランス-4-(トランス-アミノメチルシクロヘキサンカルボニル)アミノメチルシクロヘキサンカルボン酸)、トラネキサム酸とハイドロキノンのエステル体(例えば、トランス-4-アミノメチルシクロヘキサンカルボン酸4’-ヒドロキシフェニルエステル)、トラネキサム酸とゲンチシン酸のエステル体(例えば、2-(トランス-4-アミノメチルシクロヘキシルカルボニルオキシ)-5-ヒドロキシ安息香酸及びその塩)、トラネキサム酸のアミド体(例えば、トランス-4-アミノメチルシクロヘキサンカルボン酸メチルアミド及びその塩、トランス-4-(p-メトキシベンゾイル)アミノメチルシクロヘキサンカルボン酸及びその塩、トランス-4-グアニジノメチルシクロヘキサンカルボン酸及びその塩等が挙げられる。 Examples of tranexamic acid and its derivatives include tranexamic acid (trans-4-aminomethylcyclohexanecarboxylic acid (t-AMCHA)), tranexamic acid dimer (for example, trans-4-(trans-aminomethylcyclohexanecarbonyl)amino hydrochloride), methylcyclohexanecarboxylic acid), esters of tranexamic acid and hydroquinone (e.g., trans-4-aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester), esters of tranexamic acid and gentisic acid (e.g., 2-(trans-4 -aminomethylcyclohexylcarbonyloxy)-5-hydroxybenzoic acid and its salts), amide derivatives of tranexamic acid (for example, trans-4-aminomethylcyclohexanecarboxylic acid methylamide and its salts, trans-4-(p-methoxybenzoyl)) Examples include aminomethylcyclohexanecarboxylic acid and salts thereof, trans-4-guanidinomethylcyclohexanecarboxylic acid and salts thereof.
レゾルシン誘導体としては、4-n-ブチルレゾルシノール、4-イソアミルレゾルシノール等が挙げられる。 Examples of resorcinol derivatives include 4-n-butylresorcinol and 4-isoamylresorcinol.
ニコチン酸誘導体としては、ニコチン酸アミド、ニコチン酸ベンジル等が挙げられる。 Examples of nicotinic acid derivatives include nicotinamide, benzyl nicotinate, and the like.
セロトニン誘導体としては、クマロイルセロトニン及びフェルロイルセロトニン等が挙げられる。 Examples of serotonin derivatives include coumaroyl serotonin and feruloyl serotonin.
サリチル酸誘導体としては、3-メトキシサリチル酸、4-メトキシサリチル酸及び5-メトキシサリチル酸、及びそれらの塩が挙げられる。 Salicylic acid derivatives include 3-methoxysalicylic acid, 4-methoxysalicylic acid and 5-methoxysalicylic acid, and salts thereof.
アルキルフェノール類としては、ルシノール(4-n-ブチルレソルシノール)、マグノリグナン、ビフェニル化合物、ロドデノール等が挙げられる。 Examples of the alkylphenols include rucinol (4-n-butylresorcinol), magnolignan, biphenyl compounds, rhododenol, and the like.
上記化合物の塩としては、ナトリウム塩、カリウム塩等のアルカリ金属塩;カルシウム塩、マグネシウム塩等のアルカリ土類金属塩;メチルアミン塩、ジエチルアミン塩、トリメチルアミン塩、トリエチルアミン塩、エタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩、エチレンジアミン塩、トリス(ヒドロキシメチル)メチルアミン塩、ジシクロヘキシルアミン塩、N,N’-ジベンジルエチレンジアミン塩、アルカノールアミン塩等のアンモニウム塩;および塩基性有機物塩等が挙げられる。好ましくは、ナトリウム塩、カリウム塩、マグネシウム塩、トリエタノールアミン塩等が挙げられる。 Salts of the above compounds include alkali metal salts such as sodium salts and potassium salts; alkaline earth metal salts such as calcium salts and magnesium salts; methylamine salts, diethylamine salts, trimethylamine salts, triethylamine salts, ethanolamine salts, and diethanolamine salts. , ammonium salts such as triethanolamine salt, ethylenediamine salt, tris(hydroxymethyl)methylamine salt, dicyclohexylamine salt, N,N'-dibenzylethylenediamine salt, and alkanolamine salt; and basic organic salts. Preferable examples include sodium salt, potassium salt, magnesium salt, triethanolamine salt, and the like.
美白成分としては、上記の成分から1種を単独で用いてもよいし、2種以上を組み合わせて用いてもよい。 As the whitening component, one type from the above-mentioned components may be used alone, or two or more types may be used in combination.
上述の美白成分の中でも、拭き取りによる肌明度向上効果をより一層良好に得る観点から、美白成分としては、アスコルビン酸及びその誘導体が挙げられ、好ましくはアスコルビン酸誘導体が挙げられ、より好ましくはアスコルビン酸グルコシドが挙げられる。 Among the above-mentioned whitening ingredients, from the viewpoint of obtaining a better effect of improving skin brightness by wiping, whitening ingredients include ascorbic acid and its derivatives, preferably ascorbic acid derivatives, and more preferably ascorbic acid. Examples include glucosides.
本発明の方法に用いる液状外用組成物において、美白成分の含有量としては特に限定されず、美白成分の種類及び所望の肌明度向上効果に応じて適宜設定することができる。例えば、液状外用組成物中の美白成分の含有量としては、例えば0.01~5重量%、好ましくは0.1~4重要%、より好ましくは1~3重量%が挙げられる。 In the liquid external composition used in the method of the present invention, the content of the whitening component is not particularly limited, and can be appropriately set depending on the type of whitening component and the desired skin brightness improvement effect. For example, the content of the whitening component in the liquid external composition is, for example, 0.01 to 5% by weight, preferably 0.1 to 4% by weight, and more preferably 1 to 3% by weight.
一価低級アルコール及び/又はグリセリン
本発明の方法に用いる液状外用組成物は、使用感向上効果及び拭き取りによる肌明度向上効果をより一層良好に得る観点から、一価低級アルコール及び/又はグリセリンを含むことが好ましく、一価低級アルコール及びグリセリンを含むことがさらに好ましい。
Monohydric lower alcohol and/or glycerin The liquid external composition used in the method of the present invention contains a monohydric lower alcohol and/or glycerin from the viewpoint of further improving the feeling of use and improving skin brightness by wiping. It is preferable that the alcohol contains a monohydric lower alcohol and glycerin.
一価低級アルコールとしては、薬学的又は香粧学的に許容されるものであれば特に制限されないが、例えば、エタノール、プロパノール、ブタノール、ペンタノール、ヘキサノール、イソプロパノール等の炭素数2~6のアルコールが挙げられる。 The monohydric lower alcohol is not particularly limited as long as it is pharmaceutically or cosmetically acceptable, but examples include alcohols with 2 to 6 carbon atoms such as ethanol, propanol, butanol, pentanol, hexanol, and isopropanol. can be mentioned.
これらの一価低級アルコールは1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These monohydric lower alcohols may be used alone or in combination of two or more.
これらの一価低級アルコールの中でも、使用感向上効果及び拭き取りによる肌明度向上効果をより一層良好に得る観点から、好ましくはエタノールが挙げられる。 Among these monohydric lower alcohols, ethanol is preferred from the viewpoint of obtaining better effects of improving the feeling of use and improving skin brightness by wiping.
本発明の方法に用いる液状外用組成物において、一価低級アルコールの含有量としては特に限定されず、所望の肌明度向上効果に応じて適宜設定することができる。例えば、液状外用組成物中の一価低級アルコール含有量としては、1~15重量%、好ましくは2~10重量%、より好ましくは3~7重量%が挙げられる。 In the liquid external composition used in the method of the present invention, the content of monohydric lower alcohol is not particularly limited, and can be appropriately set depending on the desired skin brightness improvement effect. For example, the monohydric lower alcohol content in the liquid external composition is 1 to 15% by weight, preferably 2 to 10% by weight, and more preferably 3 to 7% by weight.
本発明の方法に用いる液状外用組成物において、美白成分と一価低級アルコールとの比率については、各成分の上記含有量によって決定されるが、美白成分1重量部に対して0.2~1500重量部、好ましくは0.5~150重量部、より好ましくは1~5重量部が挙げられる。 In the liquid external composition used in the method of the present invention, the ratio of the whitening component to the monohydric lower alcohol is determined by the above-mentioned content of each component, but is 0.2 to 1500 parts by weight per 1 part by weight of the whitening component. Parts by weight, preferably 0.5 to 150 parts by weight, more preferably 1 to 5 parts by weight.
グリセリンとしては、日本薬局方に収載されているグリセリン及び日本薬局方に収載されている濃グリセリンが挙げられる。日本薬局方に収載されているグリセリンは、日本薬局方に記載の方法で定量するとき、グリセリン(C3H8O3)84.0~87.0%を含む。日本薬局方に収載されている濃グリセリンは、日本薬局方に記載の方法で定量するとき、換算した脱水物に対し、グリセリン(C3H8O3)98.0~101.0%を含む。これらのグリセリンは1種単独で使用してもよく、また2種を組み合わせて使用してもよい。これらのグリセリンの中でも、好ましくは濃グリセリンが挙げられる。 Examples of glycerin include glycerin listed in the Japanese Pharmacopoeia and concentrated glycerin listed in the Japanese Pharmacopoeia. Glycerin listed in the Japanese Pharmacopoeia contains 84.0 to 87.0% glycerin (C 3 H 8 O 3 ) when determined by the method described in the Japanese Pharmacopoeia. Concentrated glycerin listed in the Japanese Pharmacopoeia contains 98.0 to 101.0% glycerin (C 3 H 8 O 3 ) based on the converted dehydrated product when quantitatively determined using the method described in the Japanese Pharmacopoeia. . These glycerins may be used alone or in combination of two types. Among these glycerins, concentrated glycerin is preferred.
本発明の方法に用いる液状外用組成物において、グリセリンの含有量としては特に限定されず、所望の使用感向上効果及び肌明度向上効果に応じて適宜設定することができる。例えば、液状外用組成物中のグリセリン含有量としては、グリセリン純分(C3H8O3)の総量で、例えば、1~15重量%、好ましくは2~10重量%、より好ましくは3~7重量%が挙げられる。 In the liquid external composition used in the method of the present invention, the content of glycerin is not particularly limited, and can be appropriately set depending on the desired feeling-improving effect and skin brightness-improving effect. For example, the glycerin content in the liquid external composition is, for example, 1 to 15% by weight, preferably 2 to 10 % by weight, more preferably 3 to 10% by weight , based on the total amount of pure glycerin ( C 3 H 8 O 3 ). 7% by weight.
本発明の方法に用いる液状外用組成物において、美白成分とグリセリンとの比率については、各成分の上記含量によって決定されるが、美白成分1重量部に対してグリセリン純分(C3H8O3)の総量が0.2~1500重量部、好ましくは0.5~150重量部、より好ましくは1~3重量部が挙げられる。 In the liquid external composition used in the method of the present invention, the ratio of the whitening component to glycerin is determined by the above-mentioned content of each component, but the ratio of pure glycerin (C 3 H 8 O The total amount of 3 ) is 0.2 to 1500 parts by weight, preferably 0.5 to 150 parts by weight, and more preferably 1 to 3 parts by weight.
本発明の方法に用いる液状外用組成物において、一級低級アルコールとグリセリンとの比率については、各成分の上記含量によって決定されるが、一級低級アルコール1重量部に対してグリセリン純分(C3H8O3)の総量が0.06~15重量部、好ましくは0.1~8重量部、より好ましくは0.5~1.5重量部が挙げられる。 In the liquid external composition used in the method of the present invention, the ratio of primary lower alcohol to glycerin is determined by the above-mentioned content of each component, but the ratio of pure glycerin (C 3 H The total amount of 8 O 3 ) is 0.06 to 15 parts by weight, preferably 0.1 to 8 parts by weight, more preferably 0.5 to 1.5 parts by weight.
クエン酸イオン
本発明の方法に用いる液状外用組成物は、拭き取りによる肌明度向上効果をより一層良好に得る観点から、クエン酸イオンを含むことが好ましい。
Citrate ion It is preferable that the liquid external composition used in the method of the present invention contains citrate ion from the viewpoint of obtaining an even better effect of improving skin brightness by wiping.
クエン酸イオン源としては、クエン酸及びクエン酸塩が挙げられる。クエン酸塩としては、ナトリウム塩、カリウム塩等のアルカリ金属塩;カルシウム塩、マグネシウム塩等のアルカリ土類金属塩;メチルアミン塩、ジエチルアミン塩、トリメチルアミン塩、トリエチルアミン塩、エタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩、エチレンジアミン塩、トリス(ヒドロキシメチル)メチルアミン塩、ジシクロヘキシルアミン塩、N,N’-ジベンジルエチレンジアミン塩、アルカノールアミン塩等のアンモニウム塩;および塩基性有機物塩等が挙げられる。 Sources of citric acid ions include citric acid and citrate salts. Citrates include alkali metal salts such as sodium salts and potassium salts; alkaline earth metal salts such as calcium salts and magnesium salts; methylamine salts, diethylamine salts, trimethylamine salts, triethylamine salts, ethanolamine salts, diethanolamine salts, Examples include ammonium salts such as triethanolamine salt, ethylenediamine salt, tris(hydroxymethyl)methylamine salt, dicyclohexylamine salt, N,N'-dibenzylethylenediamine salt, and alkanolamine salt; and basic organic salts.
クエン酸イオン源としては、クエン酸及びクエン酸塩のいずれか一方を単独で用いてもよいし、両者を組み合わせて用いてもよい。好ましくは、クエン酸イオン源としてクエン酸及びクエン酸塩を組み合わせて用いる。また、クエン酸塩としては、上記のクエン酸塩の中から単独で用いてもよいし、2種以上を組み合わせて用いてもよい。上記のクエン酸の中でも、好ましくはアルカリ金属塩が挙げられ、より好ましくはナトリウム塩が挙げられる。 As the citric acid ion source, either citric acid or citrate may be used alone, or both may be used in combination. Preferably, a combination of citric acid and citrate is used as the citrate ion source. Further, as the citrate, one of the above citrates may be used, or two or more thereof may be used in combination. Among the above citric acids, alkali metal salts are preferred, and sodium salts are more preferred.
本発明の方法に用いる液状外用組成物において、クエン酸イオン源の含有量としては特に限定されず、所望の肌明度向上効果に応じて適宜設定することができる。例えば、液状外用組成物中のクエン酸イオン源としては、クエン酸無水物換算量で、0.01~0.5重量%、好ましくは0.07~0.3重量%が挙げられる。 In the liquid external composition used in the method of the present invention, the content of the citric acid ion source is not particularly limited, and can be appropriately set depending on the desired skin brightness improvement effect. For example, the amount of the citric acid ion source in the liquid external composition may be 0.01 to 0.5% by weight, preferably 0.07 to 0.3% by weight in terms of citric anhydride.
アルカリ金属イオン
本発明の方法に用いる液状外用組成物は、拭き取りによる肌明度向上効果をより一層良好に得る観点から、アルカリ金属イオンを含むことが好ましい。
Alkali metal ions It is preferable that the liquid external composition used in the method of the present invention contains alkali metal ions from the viewpoint of obtaining an even better effect of improving skin brightness by wiping.
アルカリ金属イオンとしては、ナトリウムイオン及びカリウムイオンが挙げられる。これらのアルカリ金属イオンは、1種を単独で用いてもよいし、2種以上を組み合わせて用いてもよい。好ましくはナトリウムイオン及びカリウムイオンを組み合わせて用いる。 Alkali metal ions include sodium ions and potassium ions. These alkali metal ions may be used alone or in combination of two or more. Preferably, a combination of sodium ions and potassium ions is used.
アルカリ金属イオン源としては特に限定されず、上記の各成分の少なくともいずれかに該当するアルカリ金属塩化合物であってもよいし、上記のいずれの成分にも該当しないアルカリ金属塩化合物であってもよい。上記のいずれの成分にも該当しないアルカリ金属塩化合物としては、水酸化ナトリウム、水酸化カリウム等のアルカリ金属水酸化物;炭酸水素ナトリウム、炭酸ナトリウム、リン酸ナトリウム、リン酸カリウム等の弱酸と強塩基との塩(緩衝塩);硫酸ナトリウム、硫酸カリウム、塩化ナトリウム、塩化カリウム等の中性塩等が挙げられる。 The alkali metal ion source is not particularly limited, and may be an alkali metal salt compound that falls under at least one of the above components, or an alkali metal salt compound that does not fall under any of the above components. good. Alkali metal salt compounds that do not fall under any of the above components include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; weak acids and strong acids such as sodium bicarbonate, sodium carbonate, sodium phosphate, and potassium phosphate. Salts with bases (buffer salts); examples include neutral salts such as sodium sulfate, potassium sulfate, sodium chloride, potassium chloride, and the like.
これらのアルカリ金属イオン源は、1種を単独で用いてもよいし、2種以上を組み合わせて用いてもよい。 These alkali metal ion sources may be used alone or in combination of two or more.
これらのアルカリ金属イオン源の中でも、好ましくは、上記のクエン酸イオン源に該当するアルカリ金属塩(つまりクエン酸アルカリ金属塩)及びアルカリ金属水酸化物が挙げられ、より好ましくは、クエン酸ナトリウム及び水酸化カリウムが挙げられる。 Among these alkali metal ion sources, preferable examples include alkali metal salts (that is, alkali metal citrate salts) and alkali metal hydroxides corresponding to the above-mentioned citrate ion sources, and more preferable examples include sodium citrate and alkali metal hydroxides. Potassium hydroxide is mentioned.
本発明の方法に用いる液状外用組成物において、アルカリ金属イオン源の含有量としては特に限定されず、所望の肌明度向上効果に応じて適宜設定することができる。例えば、アルカリ金属イオン源としてナトリウムイオンが含まれる場合、液状外用組成物中のナトリウムイオン源の含有量としては、ナトリウム換算量で、0.01~0.5重量%、0.05~0.14重量%が挙げられる。アルカリ金属イオン源としてカリウムイオンが含まれる場合、液状外用組成物中のカリウムイオン源の含有量としては、カリウム換算量で、0.01~0.5重量%、0.2~0.4重量%が挙げられる。 In the liquid external composition used in the method of the present invention, the content of the alkali metal ion source is not particularly limited, and can be appropriately set depending on the desired skin brightness improvement effect. For example, when sodium ions are included as the alkali metal ion source, the content of the sodium ion source in the liquid external composition is 0.01 to 0.5% by weight, 0.05 to 0.5% by weight in terms of sodium. 14% by weight. When potassium ions are included as the alkali metal ion source, the content of the potassium ion source in the liquid external composition is 0.01 to 0.5% by weight, 0.2 to 0.4% by weight in terms of potassium. % is mentioned.
その他の成分
本発明の方法に用いる液状外用組成物には、上記の成分以外に、必要に応じて、他の薬理成分を含有していてもよい。このような薬理成分としては、例えば、抗ヒスタミン剤(ジフェンヒドラミン、ジフェンヒドラミン塩酸塩、マレイン酸クロルフェニラミン等)、局所麻酔剤(リドカイン、ジブカイン、アミノ安息香酸メチル、プロカイン、テトラカイン、ブピパカイン、メピパカイン、クロロプロカイン、プロパラカイン、メプリルカイン又はこれらの塩、オルソカイン、オキセサゼイン、オキシポリエントキシデカン、ロートエキス、ペルカミンパーゼ、テシットデシチン等)、抗炎症剤(アラントイン、グリチルリチン酸、グリチルリチン酸メチル、グリチルリチン酸ステアリル、グリチルリチン酸ジカリウム、グリチルリチン酸モノアンモニウム、グリチルレチン酸、グリチルレチン酸ピリドキシン、グリチルレチン酸ステアリル、グリチルレチン酸グリセリル、グリチルレチン酸モノグルクロニド、サリチル酸、サリチル酸メチル、サリチル酸グリコール、インドメタシン、フェルビナク、ジクロフェナクナトリウム、ロキソプロフェンナトリウム、ウフェナマート、イブプロフェンピコノール、スプロフェン、ベンダザック、スプロフェン、ブフェキサマク等)、殺菌剤(ベンザルコニウム塩化物、デカリニウム塩化物、ベンゼトニウム塩化物、セチルピリジニウム塩化物、クロルヘキシジン塩化物、グルコン酸クロルヘキシジン、イソプロピルメチルフェノール、アンモニア水、スルファジアジン、乳酸、フェノール等)、皮膚保護剤(コロジオン、ヒマシ油等)、血行促進剤(ノニル酸ワニリルアミド、ニコチン酸ベンジルエステル、カプサイシン、トウガラシエキス等)、清涼化剤(メントール、カンフル等)、ビタミン類(ビタミンA、B、D等)、ムコ多糖類(コンドロイチン硫酸ナトリウム、グルコサミン、ヒアルロン酸及びその塩等)、グリセリン以外の多価アルコール(プロピレングリコール、エチレングリコール、1,3-ブチレングリコール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール等)、湿潤剤(dl-ピロリドンカルボン酸ナトリウム液、D-ソルビトール液、マクロゴール等)、植物抽出物(モクレン科モクレン属植物、例えば、マグノリア・ビロバ、ボウシュンカ、ハクモクレン、コブシ(ヤマアララギ、コブシハジカミ、イモウエバナ)、モクレン(モクレンゲ、シモクレン)、カラホオ(シナホオノキ)、マグノリア・スプレンゲリ、ホオノキ(ホオガシワ、ホオガシワノキ、ウマノベロ)等の抽出物;バラ科サクラ属植物、例えば、プルーン(セイヨウスモモ)、アンズ(カラモモ)、プルヌス・コンラディナエ、カスミザクラ(ケヤマザクラ)、チョウジザクラ、イヌザクラ、ウワミズザクラ、ヤマザクラ、マメザクラ(フジザクラ)、シダレザクラ(イトザクラ)、ニワウメ(コウメ、リンショウバイ)、カンザン(セキヤマ)、オオシマザクラ、ミヤマザクラ、ウメ、ミネザクラ、ブンゴウメ、チシマザクラ、モモ、エドヒガン(ウバヒガン)、スモモ(ハタンキョウ)、オオヤマザクラ、リンボク(ヒイラギガシ)、シウリザクラ(ミヤマイヌザクラ、シオリザクラ)、ヒガンザクラ(コヒガンザクラ)、ソメイヨシノ、バクチノキ(ビラン、ビランジュ)等の抽出物)等が挙げられる。
Other Components In addition to the above-mentioned components, the liquid external composition used in the method of the present invention may contain other pharmacological components as necessary. Such pharmacological ingredients include, for example, antihistamines (diphenhydramine, diphenhydramine hydrochloride, chlorpheniramine maleate, etc.), local anesthetics (lidocaine, dibucaine, methyl aminobenzoate, procaine, tetracaine, bupipacaine, mepipacaine, chloroprocaine). , proparacaine, meprilcaine or their salts, orthocaine, oxesazein, oxypolyentoxydecane, rhoto extract, percaminpase, tesitdesitin, etc.), anti-inflammatory agents (allantoin, glycyrrhizic acid, methyl glycyrrhizinate, stearyl glycyrrhizinate, dipotassium glycyrrhizinate, glycyrrhizic acid) Monoammonium, glycyrrhetinic acid, pyridoxine glycyrrhetinate, stearyl glycyrrhetinate, glyceryl glycyrrhetinate, monoglucuronide glycyrrhetinate, salicylic acid, methyl salicylate, glycol salicylate, indomethacin, felbinac, diclofenac sodium, loxoprofen sodium, ufenamate, ibuprofen piconol, suprofen, bender Zac, Suprofen, Bufexamac, etc.), disinfectants (benzalkonium chloride, dequalinium chloride, benzethonium chloride, cetylpyridinium chloride, chlorhexidine chloride, chlorhexidine gluconate, isopropylmethylphenol, aqueous ammonia, sulfadiazine, lactic acid, phenol) ), skin protectants (collodion, castor oil, etc.), blood circulation promoters (nonylic acid vanillylamide, nicotinic acid benzyl ester, capsaicin, chili pepper extract, etc.), cooling agents (menthol, camphor, etc.), vitamins (vitamin A, B, D, etc.), mucopolysaccharides (sodium chondroitin sulfate, glucosamine, hyaluronic acid and its salts, etc.), polyhydric alcohols other than glycerin (propylene glycol, ethylene glycol, 1,3-butylene glycol, isoprene glycol, diethylene glycol, diethylene glycol, propylene glycol, etc.), wetting agents (dl-pyrrolidone carboxylic acid sodium solution, D-sorbitol solution, macrogol, etc.), plant extracts (Magnoliaceae, Magnolia genus plants, such as Magnolia biloba, Bosunca japonica, White magnolia, Kobushi (porus porcupine), Extracts of magnolias (Magnolia, Magnolia), Karaho (Chinese Magnolia), Magnolia sprengelii, Magnolia (Magnolia sprengelii, Magnolia sprangeri); Rosaceae plants of the Prunus genus, such as prunes, apricots (Prunus conradinae, Kasumizakura), Clove cherry, Dog cherry, Uwamizuzakura, Yamazakura, Mamezakura (Fujizakura), Weeping cherry (Itozakura), Niwaume (Kouume, Rinshobai), Kanzan (Sekiyama), Oshimazakura, Miyamazakura, Plum, Minezakura, Bungoume, Chishimazakura, Peach, Edohigan (Ubahigan), Plum (Hatankyo), Oyamazakura, Linbok (Hiiragigashi), Shiurizakura (Miyaminezakura, Shiorizakura), Higanzakura (Kohiganzakura), Someiyoshino cherry, Bakuchinoki (Biran, Biranju) etc.).
また、本発明の方法に用いる液状外用組成物は、所望の製剤形態にするために、必要に応じて、基剤や添加剤が含まれていてもよい。このような基剤や添加剤については、薬学的又は香粧学的に許容されることを限度として特に制限されないが、例えば、水;油類(オリーブ油、サフラワー油、大豆油、つばき油、とうもろこし油、なたね油、ひまわり油、綿実油、落花生油、ラード、スクワラン、魚油等)、鉱物油(流動パラフィン、パラフィン、ゲル化炭化水素、ワセリン等)、ワックス類・ロウ類(ミツロウ、カルナウバロウ、キャンデリラロウ、セレシン、ライスワックス、マイクロクリスタリンワックス等)、エステル油(ミリスチン酸イソプロピル、アジピン酸イソプロピル、セバシン酸ジエチル、セバシン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸セチル、オレイン酸エチル、トリ2-エチルヘキサン酸グリセリル等)、脂肪酸アルキルエステル、脂肪酸(ステアリン酸、オレイン酸、パルミチン酸、ベヘン酸、リノール酸、ラノリン等)、脂肪酸エステル(パルミチン酸セチル、パルミチン酸イソプロピル、リノール酸エチル等)、中鎖脂肪酸トリグリセリド、高級アルコール(ステアリルアルコール、セタノール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、ヘキサデシルアルコール、ラノリンアルコール、コレステロール、ジヒドロコレステロール、フィトステロール、ラウリルアルコール、セトステアリルアルコール、リノレイルアルコール、オクチルドデカノール、ヘキシルデカノール、イソステアリルアルコール等)、2-エチルヘキサン酸セチル、シリコーンオイル(ジメチルポリシロキサン、環状シリコーン等)等の油性基剤;POE(10~50モル)フィトステロールエーテル、POE(10~50モル)ジヒドロコレステロールエーテル、POE(10~50モル)2-オクチルドデシルエーテル、POE(10~50モル)デシルテトラデシルエーテル、POE(10~50モル)オレイルエーテル、POE(2~50モル)セチルエーテル、POE(5~50モル)ベヘニルエーテル、POE(5~30モル)ポリオキシプロピレン(5~30モル)2-デシルテトラデシルエーテル、POE(10~50モル)ポリオキシプロピレン(2~30モル)セチルエーテルなどのポリオキシエチレンアルキルエーテル、これらのリン酸・リン酸塩(POEセチルエーテルリン酸ナトリウムなど)、POE(20~60モル)ソルビタンモノオレート、POE(10~60モル)ソルビタンモノイソステアレート、POE(10~80モル)グリセリルモノイソステアレート、POE(10~30モル)グリセリルモノステアレート、POE(20~100モル)・ポリオキシプロピレン変性シリコーン、POE・アルキル変性シリコーン、モノラウリン酸ポリエチレングリコール、モノパルミチン酸ポリエチレングリコール、モノステアリン酸ポリエチレングリコール、ジラウリン酸ポリエチレングリコール、ジパルミチン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、ジオレイン酸ポリエチレングリコール、ジリシノレイン酸ポリエチレングリコール、ポリオキシエチレン硬化ヒマシ油(5~100)、ポリソルベート(20~85)、グリセリン脂肪酸エステル(モノステアリン酸グリセリン等)、水素添加大豆リン脂質、水素添加ラノリンアルコール等の界面活性剤;清涼化剤(メントール、カンフル、ボルネオール、ハッカ水、ハッカ油等)、防腐剤(メチルパラベン、プロピルパラベン、安息香酸、安息香酸ナトリウム、ソルビン酸等)、着香剤(シトラール、1,8-シオネール、シトロネラール、ファルネソール等)、着色剤(タール色素(褐色201号、青色201号、黄色4号、黄色403号等)、カカオ色素、クロロフィル、酸化アルミニウム等)、pH調整剤(リン酸、塩酸、コハク酸、酒石酸、トリエタノールアミン、トリイソプロパノールアミン等)、安定化剤(ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、エデト酸ナトリウム、メタリン酸ナトリウム、L-アルギニン、L-アスパラギン酸、DL-アラニン、グリシン、エリソルビン酸ナトリウム、没食子酸プロピル、亜硫酸ナトリウム、二酸化硫黄、クロロゲン酸、カテキン、ローズマリー抽出物等)、酸化防止剤、紫外線吸収剤、キレート剤、粘着剤、緩衝剤、溶解補助剤、可溶化剤、保存剤等の添加剤が挙げられる。 Further, the liquid external composition used in the method of the present invention may contain a base and additives as necessary in order to obtain a desired formulation form. Such bases and additives are not particularly limited as long as they are pharmaceutically or cosmetically acceptable, but include, for example, water; oils (olive oil, safflower oil, soybean oil, camellia oil, Corn oil, rapeseed oil, sunflower oil, cottonseed oil, peanut oil, lard, squalane, fish oil, etc.), mineral oils (liquid paraffin, paraffin, gelled hydrocarbons, petrolatum, etc.), waxes/waxes (beeswax, carnauba wax, candelilla) wax, ceresin, rice wax, microcrystalline wax, etc.), ester oil (isopropyl myristate, isopropyl adipate, diethyl sebacate, isopropyl sebacate, isopropyl palmitate, cetyl palmitate, ethyl oleate, tri-2-ethylhexanoic acid) fatty acid alkyl ester, fatty acid (stearic acid, oleic acid, palmitic acid, behenic acid, linoleic acid, lanolin, etc.), fatty acid ester (cetyl palmitate, isopropyl palmitate, ethyl linoleate, etc.), medium chain fatty acid triglyceride , higher alcohols (stearyl alcohol, cetanol, behenyl alcohol, myristyl alcohol, oleyl alcohol, hexadecyl alcohol, lanolin alcohol, cholesterol, dihydrocholesterol, phytosterols, lauryl alcohol, cetostearyl alcohol, linoleyl alcohol, octyldodecanol, hexyldecanol, isostearyl (alcohol, etc.), cetyl 2-ethylhexanoate, oil bases such as silicone oils (dimethylpolysiloxane, cyclic silicone, etc.); POE (10 to 50 moles) phytosterol ether, POE (10 to 50 moles) dihydrocholesterol ether, POE (10-50 mol) 2-octyl dodecyl ether, POE (10-50 mol) decyl tetradecyl ether, POE (10-50 mol) oleyl ether, POE (2-50 mol) cetyl ether, POE (5-50 mol) ) Polyoxyethylene such as behenyl ether, POE (5 to 30 moles) polyoxypropylene (5 to 30 moles) 2-decyltetradecyl ether, POE (10 to 50 moles) polyoxypropylene (2 to 30 moles) cetyl ether Alkyl ethers, phosphoric acids and phosphates of these (POE cetyl ether sodium phosphate, etc.), POE (20-60 moles) sorbitan monooleate, POE (10-60 moles) sorbitan monoisostearate, POE (10-80 moles) mol) glyceryl monoisostearate, POE (10-30 mol) glyceryl monostearate, POE (20-100 mol)/polyoxypropylene-modified silicone, POE/alkyl-modified silicone, polyethylene glycol monolaurate, polyethylene glycol monopalmitate , polyethylene glycol monostearate, polyethylene glycol dilaurate, polyethylene glycol dipalmitate, polyethylene glycol distearate, polyethylene glycol dioleate, polyethylene glycol diricinoleate, polyoxyethylene hydrogenated castor oil (5 to 100), polysorbate (20 to 85), surfactants such as glycerin fatty acid esters (glyceryl monostearate, etc.), hydrogenated soybean phospholipids, hydrogenated lanolin alcohol, etc.; cooling agents (menthol, camphor, borneol, peppermint water, peppermint oil, etc.), preservatives (methylparaben, propylparaben, benzoic acid, sodium benzoate, sorbic acid, etc.), flavoring agents (citral, 1,8-cyonel, citronellal, farnesol, etc.), colorants (tar pigments (brown No. 201, blue No. 201, Yellow No. 4, Yellow No. 403, etc.), cacao pigment, chlorophyll, aluminum oxide, etc.), pH adjusters (phosphoric acid, hydrochloric acid, succinic acid, tartaric acid, triethanolamine, triisopropanolamine, etc.), stabilizers (dibutyl hydroxy Toluene, butylhydroxyanisole, sodium edetate, sodium metaphosphate, L-arginine, L-aspartic acid, DL-alanine, glycine, sodium erythorbate, propyl gallate, sodium sulfite, sulfur dioxide, chlorogenic acid, catechin, rosemary. Extracts, etc.), antioxidants, ultraviolet absorbers, chelating agents, adhesives, buffers, solubilizing agents, solubilizers, preservatives, and other additives.
製剤形態
本発明の方法に用いる液状外用組成物の製剤形態は、液状である限り特に制限されない。また、本発明の方法に用いる液状外用組成物は、水性製剤、油性製剤等の非乳化製剤であってもよく、また水中油型乳化製剤、油中水型乳化製剤等の乳化製剤であってもよいが、拭き取りによる肌明度向上効果をより一層良好に得る観点から、好ましくは、水性製剤である。
Formulation The form of the liquid external composition used in the method of the present invention is not particularly limited as long as it is liquid. Furthermore, the liquid external composition used in the method of the present invention may be a non-emulsified preparation such as an aqueous preparation or an oil-based preparation, or an emulsified preparation such as an oil-in-water emulsion or a water-in-oil emulsion. However, an aqueous preparation is preferable from the viewpoint of obtaining an even better effect of improving skin brightness by wiping.
また、本発明の方法に用いる液状外用組成物は、皮膚に適用されるものである限り、皮膚外用医薬品、医薬部外品、化粧料のいずれの製剤形態であってもよい。 Further, the liquid external composition used in the method of the present invention may be in the form of any of a skin external medicine, a quasi-drug, and a cosmetic, as long as it is applied to the skin.
前記外用組成物の製剤形態として、具体的には、液剤(ローション剤、スプレー剤、エアゾール剤、及び乳液剤を含む)、乳液、化粧水、ローションが挙げられ、好ましくは、ローション剤、化粧水、ローションが挙げられる。これらの製剤形態への調製は、第十六改正日本薬局方 製剤総則等に記載の公知の方法に従って、製剤形態に応じた添加剤を用いて製剤化することにより行うことができる。 Specific examples of the formulation form of the external composition include liquids (including lotions, sprays, aerosols, and emulsions), emulsions, lotions, and lotions, and preferably lotions and lotions. , lotion. These formulations can be prepared by using additives appropriate for the formulation according to the known methods described in the 16th edition of the Japanese Pharmacopoeia, General Rules for Preparations, etc.
清拭具
本発明の方法では、肌表面を拭き取るために清拭具を用いる。本発明の方法では、清拭具に液状外用組成物を含浸させ、肌表面上を滑らせることで、肌表面を拭き取るようにして液状外用組成物を塗布する。この時、上記の組成を有する液状外用組成物と清拭具とにより角質層表面の老化角質を拭き取る(除去する)と同時に、新たに露出した角質層表面が最初に当該液状外用組成物中の美白成分と接触できる。角質層表面に接触した美白成分が角質層内部に浸透し、メラニン生成を抑制及び/又は生成メラニンを希釈化することで、肌明度を向上させる。
Cleaning Tool In the method of the present invention, a cleaning tool is used to wipe the skin surface. In the method of the present invention, the liquid external composition is applied to the skin surface by impregnating the cleaning tool with the liquid external composition and sliding it on the skin surface in a wiping manner. At this time, the aged keratin on the surface of the stratum corneum is wiped off (removed) using the liquid external composition having the above composition and the wiping tool, and at the same time, the newly exposed surface of the stratum corneum is first exposed to the liquid composition in the liquid external composition. Can come into contact with whitening ingredients. The whitening component that comes into contact with the surface of the stratum corneum penetrates into the stratum corneum and suppresses melanin production and/or dilutes the produced melanin, thereby improving skin brightness.
清拭具としては、液状外用組成物を含浸させることが可能な吸収性基材であれば特に制限されない。具体的には、繊維基材が挙げられる。繊維基材としては、織布及び不織布を問わないが、拭き取りによる肌明度向上効果をより一層良好に得る観点から、好ましくは繊維積層物が挙げられ、より好ましくは、不織布の中でも、ある程度厚みがある繊維積層物(いわゆる化粧用コットンパフ)が挙げられる。 The wiping tool is not particularly limited as long as it is an absorbent base material that can be impregnated with a liquid external composition. Specifically, a fiber base material can be mentioned. The fiber base material may be a woven fabric or a non-woven fabric, but from the viewpoint of better obtaining the effect of improving skin brightness by wiping, a fiber laminate is preferable, and among non-woven fabrics, a fiber laminate is more preferable. Mention may be made of certain fiber laminates (so-called cosmetic cotton puffs).
繊維基材の材料としては、植物又は動物由来の天然繊維及び化学繊維が挙げられる。植物由来の天然繊維としては、綿、パルプ等が挙げられ、動物由来の天然繊維としては、シルク、キチン、コラーゲン繊維等が挙げられる。化学繊維としては、レーヨン、キュプラ、ポリエステル、ポリアミド、ポリプロピレン、ポリアクリルニトリルが挙げられる。これらの繊維は、1種を単独で用いてもよいし、2種以上を組み合わせて用いてもよい。これらの繊維の中でも、拭き取りによる肌明度向上効果をより一層良好に得る観点から、好ましくは綿が挙げられる。つまり、拭き取りによる肌明度向上効果をより一層良好に得る観点から、清拭具は綿繊維のみから構成されることが特に好ましい。 Materials for the fiber base material include natural fibers and chemical fibers derived from plants or animals. Examples of natural fibers derived from plants include cotton and pulp, and examples of natural fibers derived from animals include silk, chitin, and collagen fibers. Examples of chemical fibers include rayon, cupro, polyester, polyamide, polypropylene, and polyacrylonitrile. These fibers may be used alone or in combination of two or more. Among these fibers, cotton is preferred from the viewpoint of obtaining even better effects of improving skin brightness by wiping. That is, from the viewpoint of obtaining even better effects of improving skin brightness by wiping, it is particularly preferable that the wiping tool is made of only cotton fibers.
肌の明度向上
本発明の方法では、上記の液状外用組成物を、清拭具に含浸させて肌表面を拭き取る用途で用いることによって、肌の明度を向上させる。肌の明度は、L*a*b*表色系における明度指数L*値を測定することで評価することができる。つまり、本発明の方法による肌の明度の向上は、肌表面のL*値の上昇によって評価することができる。
Improving skin brightness In the method of the present invention, the skin brightness is improved by impregnating a wiping tool with the liquid external composition and using it for wiping the skin surface. The lightness of the skin can be evaluated by measuring the lightness index L * value in the L * a * b * color system. That is, improvement in skin brightness by the method of the present invention can be evaluated by an increase in the L * value of the skin surface.
本発明の方法を適用する肌の部分としては、肌明度の低下を自覚する部分であれば特に限定されないが、物理的刺激及び紫外線刺激を受けやすい顔が好ましい。さらに、本発明の方法は、メラニンの沈着が起こっていない部分において明度を向上させることができるのみならず、メラニンの沈着が起こっている部分の肌においては、メラニンの沈着が起こっていない部分に比べて一層顕著に明度を向上させることができる。このため、本発明の方法を適用する肌の部分としては、メラニンの沈着が起こっている部分を含むことが特に好ましい。メラニンの沈着が起こっている部分としては、しみ、そばかすが挙げられ、より好ましくはシミが挙げられる。つまり、本発明の方法は、特に、上記の液状外用組成物をシミ対策の用途で用いる場合に有効である。 The skin area to which the method of the present invention is applied is not particularly limited as long as it is a part where a decrease in skin brightness is noticed, but preferably the face is susceptible to physical stimulation and ultraviolet stimulation. Furthermore, the method of the present invention can not only improve the brightness in areas where melanin deposition has not occurred, but also improve the brightness in areas where melanin deposition has occurred. The brightness can be improved more markedly compared to the conventional method. Therefore, it is particularly preferable that the skin area to which the method of the present invention is applied includes an area where melanin is deposited. Areas where melanin is deposited include age spots and freckles, and more preferably age spots. That is, the method of the present invention is particularly effective when the above-mentioned liquid external composition is used for stain prevention.
適用対象
本発明の方法の適用対象としては、老若男女を問わないが、特に、ターンオーバーの乱れにより角質層表面に老化角質がとどまりやすい35歳以上、好ましくは40歳以上の人が好ましい。このような年齢層の人であれば、拭き取りによる肌明度向上効果をより一層良好に得ることが期待できる。また、このような年齢層の人は、本発明の方法により一層顕著に明度を向上させることができるシミを自覚する人も多い点で好ましい。本発明の方法の好ましい適用対象年齢の上限は特に限定されないが、拭き取りによる肌明度向上効果を効果的に得る観点から、80歳未満、好ましくは70歳未満、より好ましくは60歳未満が挙げられる。
Target of application The method of the present invention can be applied to people of any age or gender, but it is particularly preferable for people over 35 years old, preferably over 40 years old, who tend to retain aged keratin on the surface of the stratum corneum due to disordered turnover. People in this age group can be expected to obtain even better effects of improving skin brightness by wiping. Further, people in this age group are preferable in that many of them are aware of age spots whose brightness can be improved more markedly by the method of the present invention. The upper limit of the age to which the method of the present invention is preferably applied is not particularly limited, but from the viewpoint of effectively obtaining the effect of improving skin brightness by wiping, examples include those under 80 years old, preferably under 70 years old, and more preferably under 60 years old. .
用法・用量
本発明の方法においては、液状外用組成物を含浸させた清拭具を用いて肌表面を拭き取ればよい。具体的には、清拭具に液状外用組成物を含浸させ、肌表面上を滑らせることで、肌表面を拭き取るようにして液状外用組成物を塗布することができる。拭き取りによる肌明度向上効果をより一層良好に得る観点から、拭き取り操作は洗顔の後の肌に対して行うことが好ましい。
Usage/Dosage In the method of the present invention, the skin surface may be wiped using a wiping tool impregnated with the liquid external composition. Specifically, the liquid external composition can be applied to the skin surface by impregnating the cleaning tool with the liquid external composition and sliding it on the skin surface in a wiping manner. From the viewpoint of obtaining even better effects of improving skin brightness by wiping, it is preferable to perform the wiping operation on the skin after washing the face.
1回の拭き取り操作当たりの液状外用組成物の使用量としては、清拭具に十分含浸させる量であればよいが、好ましくは1~6mLが挙げられる。1日当たりの拭き取り操作の数として、1回~3回、好ましくは2回が挙げられる。本発明の方法による肌の明度向上効果を効果的に得るためには、液状外用組成物による拭き取り操作を継続することが好ましい。このような観点から、本発明の方法は、好ましくは3週間以上継続して行うことが好ましい。 The amount of the liquid external composition to be used per one wiping operation may be an amount sufficient to impregnate the wiping tool, but is preferably 1 to 6 mL. The number of wiping operations per day is 1 to 3 times, preferably 2 times. In order to effectively obtain the effect of improving skin brightness by the method of the present invention, it is preferable to continue the wiping operation with the liquid external composition. From this point of view, the method of the present invention is preferably carried out continuously for three weeks or more.
2.液状外用組成物
上述のとおり、美白成分を含む液状外用組成物を含浸させた清拭具を用いて肌表面を拭き取ることで、肌明度を向上させることができる。従って、本発明は、更に、清拭具に含浸させて肌表面を拭き取るために用いられる、美白成分を含む液状外用組成物も提供する。液状外用組成物の具体的な組成、製剤形態、含浸に用いられる清拭具、使用方法、適用対象、用法・用量等については、上記「1.肌の明度向上方法」に記載の通りである。
2. Liquid External Composition As mentioned above, skin brightness can be improved by wiping the skin surface using a wiping tool impregnated with a liquid external composition containing a whitening ingredient. Therefore, the present invention further provides a liquid external composition containing a whitening component, which is used to impregnate a cleaning tool and wipe the skin surface. The specific composition of the liquid external composition, formulation form, wiping tool used for impregnation, method of use, target for application, dosage and administration, etc. are as described in "1. Method for improving skin brightness" above. .
以下に実施例を示して本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited thereto.
試験例
[液状外用組成物の調製]
表1に記載の液状外用組成物を調製した。
Test example [Preparation of liquid external composition]
Liquid external compositions listed in Table 1 were prepared.
[試験手順]
(1)両頬にシミのある40代と50代の2名の被験者を選定した。
(2)被験者の、一方の頬におけるシミ部分及び非シミ部分と、他方の頬におけるシミ部分及び非シミ部分と、額(Ctrl)と、のL*値を、分光測色計CM-2600d(コニカミノルタ)を用い、各部位5回ずつ測定し、それぞれ平均値(0w L*(シミ)、0w L*(非シミ)、及び0w L*(Ctrl))を導出した。
(3)朝晩2回3週間、洗顔後に、上記の液状外用組成物4mL/回(2mL/回/片頬)を、綿繊維のみからなる化粧用コットンパフに含浸させ、一方の頬においては、シミ部分と非シミ部分との両方でパッティングによる塗布を行い、他方の頬においては、シミ部分と非シミ部分との両方でふき取るように塗布を行った。なお、額には液状外用組成物を適用しなかった。
(4)3週間後、上記2と同様にして、各部位のL*値を5回ずつ測定し、それぞれ平均値(3w L*(シミ)、3w L*(非シミ)、及び3w L*(Ctrl))を導出した。
[Procedure of test]
(1) Two subjects, one in their 40s and one in their 50s, who had spots on both cheeks were selected.
(2) The L * values of the subject's blemish and non-stain areas on one cheek, the blemish and non-stain areas on the other cheek, and the forehead (Ctrl) were measured using a spectrophotometer CM-2600d ( Konica Minolta), each site was measured five times, and the average values (0w L * (stain), 0w L * (non-stain), and 0w L * (Ctrl)) were derived.
(3) After washing your face twice in the morning and evening for 3 weeks, impregnate a cosmetic cotton puff made only of cotton fibers with 4 mL/time (2 mL/time/one cheek) of the above liquid external composition. Application was performed by patting on both the stained and non-stained areas, and on the other cheek, the application was applied by wiping on both the stained and non-stained areas. Note that the liquid external composition was not applied to the forehead.
(4) After 3 weeks, the L * value of each part was measured 5 times in the same manner as in 2 above, and the average value (3w L * (spot), 3w L * (non-spot), and 3w L * (Ctrl)) was derived.
[結果]
以下の式に基づいて、液状外用組成物適用前と比較した適用後における非シミ部分の明度の変化(ΔΔL*)を算出した。結果を図1に示す。
ΔΔL*={3w L*(非シミ)-3w L*(Ctrl)}-{0w L*(非シミ)-0w L*(Ctrl)}
[result]
Based on the following formula, the change in brightness (ΔΔL * ) of the non-stain area after application of the liquid external composition compared with before application was calculated. The results are shown in Figure 1.
ΔΔL * = {3w L * (non-stain) - 3w L * (Ctrl)} - {0w L * (non-stain) - 0w L * (Ctrl)}
以下の式に基づいて、液状外用組成物適用前と比較した適用後におけるシミ部分の明度の変化(ΔΔL*)を算出した。結果を図2に示す。
ΔΔL*={3w L*(シミ)-3w L*(Ctrl)}-{0w L*(シミ)-0w L*(Ctrl)}
Based on the following formula, the change in brightness (ΔΔL * ) of the stain area after application of the liquid external composition compared with before application was calculated. The results are shown in Figure 2.
ΔΔL * = {3w L * (stain) - 3w L * (Ctrl)} - {0w L * (stain) - 0w L * (Ctrl)}
図1及び図2に示されるとおり、液状外用組成物の単なる塗布に比べ、液状外用組成物の拭き取り操作を行った方の肌明度について、非シミ部及びシミ部のいずれにおいても優れた向上効果が認められた。特に、図2に示されるとおり、シミ部におけるL*値上昇は1.9という驚くべき程度で得られており、肌明度の向上効果が極めて顕著に認められた。本実施例で得られたこのような効果は、単なる拭き取り操作や単なる美白成分入り液状外用組成物の塗布だけでは認められない程度に、非常に高い明度向上効果であると認められる。この効果は、特定の成分を含む液状外用組成物を選択したことと、拭き取る操作とを組み合わせたことによる相乗的な効果であると強く考えられる。 As shown in Figures 1 and 2, compared to simply applying the liquid topical composition, wiping off the liquid topical composition had an excellent improvement effect on skin brightness in both non-spotted and blemished areas. was recognized. In particular, as shown in FIG. 2, the L * value in the blemish area increased to a surprising degree of 1.9, and the effect of improving skin brightness was extremely noticeable. It is recognized that such an effect obtained in this example is a very high brightness improvement effect that cannot be observed by a simple wiping operation or a simple application of a liquid external composition containing a whitening ingredient. This effect is strongly considered to be a synergistic effect resulting from the combination of the selection of a liquid external composition containing a specific component and the wiping operation.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019044752A JP7405511B2 (en) | 2019-03-12 | 2019-03-12 | How to improve skin brightness |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019044752A JP7405511B2 (en) | 2019-03-12 | 2019-03-12 | How to improve skin brightness |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020147510A JP2020147510A (en) | 2020-09-17 |
JP7405511B2 true JP7405511B2 (en) | 2023-12-26 |
Family
ID=72431694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019044752A Active JP7405511B2 (en) | 2019-03-12 | 2019-03-12 | How to improve skin brightness |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7405511B2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001010943A (en) | 1999-06-29 | 2001-01-16 | Nonogawa Shoji Kk | Skin lotion |
JP2002154945A (en) | 2000-11-21 | 2002-05-28 | Nonogawa Shoji Kk | Bleaching skin preparation for external use |
JP2007191438A (en) | 2006-01-20 | 2007-08-02 | Nippon Menaade Keshohin Kk | Desmosome degradation-promoting agent |
JP2008174527A (en) | 2007-01-22 | 2008-07-31 | Naris Cosmetics Co Ltd | Skin lotion for wiping |
WO2018062469A1 (en) | 2016-09-29 | 2018-04-05 | ロート製薬株式会社 | Topical dermatological composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5006056B2 (en) * | 2007-01-22 | 2012-08-22 | 株式会社ナリス化粧品 | Toilet lotion |
-
2019
- 2019-03-12 JP JP2019044752A patent/JP7405511B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001010943A (en) | 1999-06-29 | 2001-01-16 | Nonogawa Shoji Kk | Skin lotion |
JP2002154945A (en) | 2000-11-21 | 2002-05-28 | Nonogawa Shoji Kk | Bleaching skin preparation for external use |
JP2007191438A (en) | 2006-01-20 | 2007-08-02 | Nippon Menaade Keshohin Kk | Desmosome degradation-promoting agent |
JP2008174527A (en) | 2007-01-22 | 2008-07-31 | Naris Cosmetics Co Ltd | Skin lotion for wiping |
WO2018062469A1 (en) | 2016-09-29 | 2018-04-05 | ロート製薬株式会社 | Topical dermatological composition |
Non-Patent Citations (1)
Title |
---|
炭の露 クリアアップローション Cプラス ( ふきとり化粧水 ビタミンC )《ティーライフ》,2016年09月11日,https://www.amazon.co.jp/%E3%83%86%E3%82%A3%E3%83%BC%E3%83%A9%E3%82%A4%E3%83%95-%E7%82%AD%E3%81%AE%E9%9C%B2-%E3%82%AF%E3%83%AA%E3%82%A2%E3%82%A2%E3%83%83%E3%83%97%E3%83%AD%E3%83%BC%E3%82%B7%E3%83%A7%E3%83%B3-%EF%BC%A3%E3%83%97%E3%83%A9%E3%82%B9/dp/B073WQ8W33 |
Also Published As
Publication number | Publication date |
---|---|
JP2020147510A (en) | 2020-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6766047B2 (en) | Γ-diketone for the treatment and prevention of aging skin and wrinkles | |
JP6968534B2 (en) | Topical composition containing Pichia anomala and chicory root extract | |
FR2880802A1 (en) | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING EUGLENE EXTRACT | |
JPWO2004016236A1 (en) | Cosmetics | |
CA3112116A1 (en) | Low ph skin care composition and methods of using the same | |
JP2005306831A (en) | Skin care preparation for external use | |
JP2006016383A (en) | Skin care preparation for slender body and cosmetic comprising the same | |
US11213472B2 (en) | VEGFC production promoter | |
JP5787246B2 (en) | Wound healing and pressure ulcer (bed sores) treatment, including keratinocyte migration / proliferation promoter | |
US20210100725A1 (en) | Topical formulations comprising strontium and methylsulfonylmethane (msm) and methods of treatment | |
KR101886288B1 (en) | Composition comprising banyan tree, lotus, and clover serum fractions (hyperpigmentation) | |
JP7405511B2 (en) | How to improve skin brightness | |
JP5164454B2 (en) | Blood circulation promoter, joint pain relieving agent, tendonitis relieving agent, and stiff shoulder relieving agent containing hot water extract of Miso bamboo | |
JP2020033346A (en) | Topical composition containing pichia anomala and n-acetylglucosamine | |
JP2019065004A (en) | Skin normal flora improving agent and cosmetic or skin external preparation containing the same | |
JP5311704B2 (en) | Skin cosmetics | |
JP2009269851A (en) | Inhibitor of prostaglandin e2 production and its utilization | |
JP2023553098A (en) | Cosmetic composition containing sucrose ester and solvent | |
JP7305161B2 (en) | skin cosmetics | |
KR101459134B1 (en) | Cosmetic composition containing piceatannol and vitamin A (retinoids) | |
JP2023552814A (en) | Method for producing cosmetic composition containing sucrose ester and solvent | |
JP2001081038A (en) | Scavenger for active oxygen, and cosmetic and food containing the same scavenger | |
US20230139888A1 (en) | Moisturizing peel cream for enhancing skin | |
JP2020015699A (en) | Skin cosmetics | |
EP4344696A1 (en) | Functional composition for alopecia comprising centipeda minima-derived extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20190410 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220209 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221125 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221206 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230404 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230620 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230919 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20231101 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231212 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231214 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7405511 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |